Operational plan for comprehensive HIV and AIDS care and ...

of these measures and to emphasize the safe use of medicines and
the importance of adherence to treatment.
9.11 World Health Organisation Target
9.11.1 South Africa notes the World Health Organisation’s announcement
of a comprehensive strategy to realize a goal of providing
antiretroviral drugs to three million people worldwide by the year
2005. As a member state of the World Health Organisation (WHO)
it is envisaged that there will be collaboration between this
programme and WHO activities that aim to achieve the objective of
providing comprehensive care for people living with HIV and
AIDS, with due recognition of the complexities of programme
administration.
9.12 Multi-Drug Resistant Tuberculosis
9.12.1 As with TB, poor management and poor compliance with
antiretroviral therapy results in multi-drug resistant HIV, which
could impact negatively on both diseases.
9.12.2 To optimise care for HIV and AIDS patients who also have
tuberculosis it is important to develop and sustain joint management
programmes.
9.12.3 It is also critical that effective health information is imparted to
patients to ensure good patient adherence to treatment to prevent the
further spread of drug resistance, as is currently being experienced
with TB.
9.12.4 HIV-infected persons are at increased risk of infection caused by
antibiotic-resistant microorganisms. Containment of resistance to
antimicrobial agents requires the establishment of appropriate earlywarning
systems over seen by a dedicated team of experts. Key
Executive Summary 23